LifeSite News
New study puts COVID infection fatality rate at only 0.15 percent
The evaluations in the report find their basis in seroprevalence studies, that is detecting the presence of antibodies against SARS-CoV-2 in the blood serum of a population.
Fri Apr 16, 2021 - 2:12 pm EST
STANFORD, California, April 16, 2021 (LifeSiteNews) — A new study released by Professor John P. A. Ioannidis of Stanford University, California, has found that the infection fatality rate (IFR) of COVID-19 is significantly lower than previous studies indicated. According to Ioannidis, a medicine and epidemiology professor, the virus is less deadly than once thought, registering at a mere 0.15% fatality rate.
Ioannidis’ research, published in the European Journal of Clinical Investigation, considered data collected from six “systematic evaluations” of global infection with the novel coronavirus, each one taking account of between 10 and 338 individual studies from 9 to 50 countries around the world. The evaluations in Ioannidis’ report find their basis in seroprevalence studies, that is detecting the presence of antibodies against SARS-CoV-2 (the virus which causes COVID-19) in the blood serum of a population.
Seroprevalence studies differ from typical national statistics of PCR-based “confirmed cases” of the virus inasmuch as they do not simply detect active traces of SARS-CoV-2, but rather the presence of COVID antibodies, thus counting those individuals infected with the pathogen at some point but who may or may not have active viral material in their body at the time of testing.
https://www.lifesitenews.com/news/new-study-puts-covid-infection-fatality-rate-at-only-0.15-percent?utm_source=featured&utm_campaign=standard